サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1405965

神経認知評価とリハビリテーションの市場規模、シェア、動向分析レポート：コンポーネント別、事業者別、地域別、セグメント予測、2024年～2030年

Neurocognitive Assessment And Rehabilitation Market Size, Share & Trends Analysis Report By Component, By Providers, By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 145 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.94円
神経認知評価とリハビリテーションの市場規模、シェア、動向分析レポート：コンポーネント別、事業者別、地域別、セグメント予測、2024年～2030年
出版日: 2023年12月11日
発行: Grand View Research
ページ情報: 英文 145 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

神経認知評価とリハビリテーション市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の神経認知評価とリハビリテーション市場は2030年までに246億米ドルに達すると予測され、2024年から2030年までのCAGRは8.67％で拡大すると予測されています。

同市場の成長の背景には、世界の認知症患者の増加があります。世界人口の増加と、それに伴う認知症患者の増加に伴い、認知症の状態を管理し、認知機能をできるだけ長く維持するための効果的な神経認知評価とリハビリテーションの必要性が高まっています。国連の世界人口見通し報告書によると、2050年までに、世界全体で65歳以上の人口は6人に1人（16％）となり、2019年の11人に1人（9％）から増加します。

また、認知症は世界的に主要な神経疾患のひとつになると予想されています。WHOによると、世界で約5,500万人が認知症であり、その60％以上が低・中所得国に居住しています。ほぼすべての国で人口に占める高齢者の割合が増加しているため、この数は2030年には7,800万人、2050年には1億3,900万人に増加すると予想されています。

さらに、神経障害に関連する研究活動における政府のイニシアチブの高まりが、市場の成長を促進すると予想されます。例えば、英国政府は2021年11月、様々な神経変性疾患の理解と治療を改善するプロジェクトに資金を提供するため、今後5年間で4億7,000万米ドルを投資すると発表しました。この疾患には、運動ニューロン疾患（MND）、パーキンソン病、認知症、レビー小体型認知症（LBD）などが含まれます。

神経認知評価とリハビリテーション市場レポートハイライト

  • 構成要素に基づいて、市場は神経認知評価テストと神経リハビリテーション療法に分けられます。神経リハビリテーション療法分野は、神経疾患の有病率の高さ、高齢者人口の増加、神経リハビリテーション機器の技術開拓などにより、2023年の収益シェアが62%を超え、市場を独占しています。
  • 事業者別に見ると、市場はリハビリセンター、病院・診療所、在宅介護環境、理学療法センターに分けられます。2023年には、リハビリセンター分野が市場を独占しました。これは、技術の大幅な進歩により、リハビリセンターが各患者固有の要件に合わせた、より個別化された治療計画を提供できるようになったためです。
  • 北米が神経認知評価とリハビリテーション市場を独占したのは、ヘルスケア部門における研究開発の重視などの要因によるものです。この地域は、研究機関、医療系大学、民間企業による強固なエコシステムが構築されており、神経認知技術の継続的なイノベーションが促進されると期待されています。
  • 2023年6月、Cognetivity NeurosciencesはClairvoと協業し、日本を含むアジア太平洋地域でAIを活用した脳の健康管理を強化しました。この協業により、CognetivityのAIプラットフォームの導入が加速し、同地域における脳の健康に対する意識が高まることが期待されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、・範囲

  • 市場系統の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 事業環境分析
    • 業界分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 コンポーネント事業分析

  • コンポーネント市場シェア、2023年・2030年
  • セグメントダッシュボード
  • コンポーネント別の世界の神経認知評価とリハビリテーション市場の見通し
  • 以下の市場規模、予測・動向分析、2018年～2030年
    • 神経認知評価検査
    • 神経リハビリテーション療法

第5章 事業者のビジネス分析

  • 事業者の市場シェア、2023年・2030年
  • セグメントダッシュボード
  • 事業者別の世界の神経認知評価とリハビリテーション市場の見通し
  • 以下の市場規模、予測・動向分析、2018年～2030年
    • リハビリセンター
    • 病院と診療所
    • ホームケア設定
    • 理学療法センター

第6章 地域ビジネス分析

  • 地域市場シェア分析、2023年・2030年
  • 世界の地域市場のスナップショット
  • 市場規模と予測トレンド分析、2018年～2030年：
  • 北米
    • 北米の神経認知評価とリハビリテーション市場、2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州の神経認知評価とリハビリテーション市場、2018年～2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • アジア太平洋地域の神経認知評価とリハビリテーション市場、2018年～2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカの神経認知評価とリハビリテーション市場、2018年～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカの神経認知評価とリハビリテーション市場、2018年～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 企業の分類
  • 企業の市況分析
  • 戦略マッピング
    • 拡大
    • パートナーシップ
    • コラボレーション
    • その他
  • 企業プロファイル・一覧表
    • Cambridge Cognition Ltd
    • CogniFit Inc
    • Cogstate Ltd
    • CNS Vital Signs, LLC
    • Posit Science
    • HAPPYneuron
    • Constant Therapy Health
    • Neural Assembly Int AB
    • Lumos Labs
    • Cognetivity Neurosciences
    • SCHUHFRIED GmbH
    • NeuronUp
    • BrainCheck, Inc.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 4 Global neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 5 Global neurocognitive assessment and rehabilitation market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America neurocognitive assessment and rehabilitation market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 8 North America neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 9 US neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 10 US neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 11 Canada neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 12 Canada neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 13 Europe neurocognitive assessment and rehabilitation market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 15 Europe neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 16 UK neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 17 UK neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 18 Germany neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 19 Germany neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 20 France neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 21 France neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 22 Italy neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 23 Italy neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 24 Spain neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 25 Spain neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 26 Norway neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 27 Norway neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 28 Sweden neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 29 Sweden neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 30 Denmark neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 31 Denmark neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific neurocognitive assessment and rehabilitation market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 35 Japan neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 36 Japan neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 37 China neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 38 China neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 39 India neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 40 India neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 41 Australia neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 42 Australia neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 43 South Korea neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 44 South Korea neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 45 Thailand neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 46 Thailand neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 47 Latin America neurocognitive assessment and rehabilitation market, by country, 2018 - 2030 (USD Million)
  • Table 48 Latin America neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 49 Latin America neurocognitive assessment and rehabilitation market, by providers , 2018 - 2030 (USD Million)
  • Table 50 Brazil neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 51 Brazil neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 52 Mexico neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 53 Mexico neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 54 Argentina neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 55 Argentina neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa neurocognitive assessment and rehabilitation market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 59 South Africa neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 60 South Africa neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 63 UAE neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 64 UAE neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)
  • Table 65 Kuwait neurocognitive assessment and rehabilitation market, by component, 2018 - 2030 (USD Million)
  • Table 66 Kuwait neurocognitive assessment and rehabilitation market, by providers, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Childcare services market segmentation
  • Fig. 8 Market snapshot, 2023
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 PESTLE analysis
  • Fig. 15 Porter's Five Forces analysis
  • Fig. 16 Neurocognitive assessment and rehabilitation market: Component outlook and key takeaways
  • Fig. 17 Neurocognitive assessment and rehabilitation market: Component movement analysis
  • Fig. 18 Neurocognitive assessment testing market revenue, 2018 - 2030 (USD Million)
  • Fig. 19 Neurorehabilitation therapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 20 Neurocognitive assessment and rehabilitation market: Providers outlook and key takeaways
  • Fig. 21 Neurocognitive assessment and rehabilitation market: Providers movement analysis
  • Fig. 22 Rehab centers market revenue, 2018 - 2030 (USD Million)
  • Fig. 23 Hospital and clinics market revenue, 2018 - 2030 (USD Million)
  • Fig. 24 Homecare settings market revenue, 2018 - 2030 (USD Million)
  • Fig. 25 Physiotherapy centers market revenue, 2018 - 2030 (USD Million)
  • Fig. 26 Regional marketplace: key takeaways
  • Fig. 27 Regional outlook, 2023 & 2030
  • Fig. 28 Neurocognitive assessment and rehabilitation market: region movement analysis
  • Fig. 29 North America neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 30 US neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 31 Canada neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 32 Europe neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 33 Germany neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 34 UK neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 35 France neurocognitive assessment and rehabilitation Market, 2018 - 2030 (USD Million)
  • Fig. 36 Italy neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 37 Spain neurocognitive assessment and rehabilitation Market, 2018 - 2030 (USD Million)
  • Fig. 38 Sweden neurocognitive assessment and rehabilitation Market, 2018 - 2030 (USD Million)
  • Fig. 39 Norway neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 42 Japan neurocognitive assessment and rehabilitation Market, 2018 - 2030 (USD Million)
  • Fig. 43 China neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 44 India neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 45 Australia neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 51 Argentina neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 52 Middle East and Africa neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 55 UAE neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 56 Kuwait neurocognitive assessment and rehabilitation market, 2018 - 2030 (USD Million)
  • Fig. 57 Company categorization
  • Fig. 58 Strategy mapping
  • Fig. 59 Company market position analysis
目次
Product Code: GVR-4-68040-165-4

Neurocognitive Assessment And Rehabilitation Market Growth & Trends:

The global neurocognitive assessment and rehabilitation market is anticipated to reach USD 24.6 billion by 2030 and is anticipated to expand at a CAGR of 8.67% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market's growth can be attributed to the rise in dementia cases globally. With rise in global population and a corresponding increase in the number of people living with dementia, there is a growing need for effective neurocognitive assessment and rehabilitation to help individuals manage their condition and maintain their cognitive function for as long as possible. By 2050, there will be 1 in 6 (16%) people over 65 globally, accounting for an increase from 1 in 11 (9%) in 2019, according to the UN World Population Prospects report.

In addition, dementia is expected to be one of the major neurological diseases globally. According to WHO, around 55 million individuals worldwide have dementia, and more than 60% of them reside in low- and middle-income nations. It is anticipated that this number will increase to 78 million in 2030 and 139 million in 2050 due to the fact that the share of older people in the population is rising in almost every country.

Furthermore, the rising government initiatives in research activities related to neurological disorders are expected to drive market growth. For instance, in November 2021, the UK government announced an investment of USD 470 million over the next 5 years to fund projects to improve the understanding and treatment of various neurodegenerative conditions. The conditions include Motor Neurone Disease (MND), Parkinson's disease, dementia, and Lewy Body Dementia (LBD).

Neurocognitive Assessment And Rehabilitation Market Report Highlights:

  • Based on component, the market is divided into neurocognitive assessment testing and neurorehabilitation therapy. The neurorehabilitation therapy segment dominated the market with a revenue share of over 62% in 2023, owing to the high prevalence of neurological disorders, the rising geriatric population, and technological developments in neurorehabilitation devices.
  • Based on providers, the market is divided into rehab centers, hospitals and clinics, home care settings, and physiotherapy centers. The rehab centers segment dominated the market in 2023. This is due to the significant advancements in technology that have enabled rehab centers to provide more personalized treatment plans tailored to the unique requirements of each patient.
  • North America dominated the neurocognitive assessment and rehabilitation market owing to factors such as a strong emphasis on research & development in the healthcare sector. The region's robust ecosystem of research institutions, medical universities, and private industry players is expected to foster continuous innovation in neurocognitive technologies.
  • In June 2023, Cognetivity Neurosciences collaborated with Clairvo to enhance AI-powered brain health management in Japan and other regions in Asia Pacific. This collaboration is expected to accelerate the adoption of Cognetivity's AI platform and promote brain health awareness in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Component
    • 1.2.2. Providers
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Volume Price Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
    • 2.2.1. Component Outlook
    • 2.2.2. Providers Outlook
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Neurological Disorders
      • 3.2.1.2. Technological Advancement
      • 3.2.1.3. Rising Government Initiatives and Funding
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost of Technologies and Services
      • 3.2.2.2. Shortage of Trained Professionals
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis

Chapter 4. Component Business Analysis

  • 4.1. Component Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Neurocognitive Assessment and Rehabilitation Market by Component Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Neurocognitive Assessment Testing
      • 4.4.1.1. Neurocognitive Assessment Testing Market, 2018 - 2030 (USD Million)
    • 4.4.2. Neurorehabilitation Therapy
      • 4.4.2.1. Neurorehabilitation Therapy Market, 2018 - 2030 (USD Million)

Chapter 5. Providers Business Analysis

  • 5.1. Providers Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Neurocognitive Assessment and Rehabilitation Market by Providers Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Rehab Centers
      • 5.4.1.1. Rehab Centers Market, 2018 - 2030 (USD Million)
    • 5.4.2. Hospital and Clinics
      • 5.4.2.1. Hospital and Clinics Market, 2018 - 2030 (USD Million)
    • 5.4.3. Homecare Settings
      • 5.4.3.1. Homecare Settings Market, 2018 - 2030 (USD Million)
    • 5.4.4. Physiotherapy Centers
      • 5.4.4.1. Physiotherapy Centers Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Global Regional Market Snapshot
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Target Population Analysis
      • 6.4.2.2. Regulatory Landscape
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Target Population Analysis
      • 6.4.3.2. Regulatory Landscape
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Target Population Analysis
      • 6.5.2.2. Regulatory Landscape
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. Germany Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.5.3. UK
      • 6.5.3.1. Target Population Analysis
      • 6.5.3.2. Regulatory Landscape
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. UK Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Target Population Analysis
      • 6.5.4.2. Regulatory Landscape
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Target Population Analysis
      • 6.5.5.2. Regulatory Landscape
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Target Population Analysis
      • 6.5.6.2. Regulatory Landscape
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Target Population Analysis
      • 6.5.7.2. Regulatory Landscape
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Denmark Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Target Population Analysis
      • 6.5.8.2. Regulatory Landscape
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Sweden Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Target Population Analysis
      • 6.5.9.2. Regulatory Landscape
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Norway Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.2.1. Asia Pacific Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Target Population Analysis
      • 6.6.2.2. Regulatory Landscape
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Target Population Analysis
      • 6.6.3.2. Regulatory Landscape
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Target Population Analysis
      • 6.6.4.2. Regulatory Landscape
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Target Population Analysis
      • 6.6.5.2. Regulatory Landscape
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Target Population Analysis
      • 6.6.6.2. Regulatory Landscape
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Target Population Analysis
      • 6.6.7.2. Regulatory Landscape
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Target Population Analysis
      • 6.7.2.2. Regulatory Landscape
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.7.3. Mexico
      • 6.7.3.1. Target Population Analysis
      • 6.7.3.2. Regulatory Landscape
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Mexico Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.7.4. Argentina
      • 6.7.4.1. Target Population Analysis
      • 6.7.4.2. Regulatory Landscape
      • 6.7.4.3. Competitive Insights
      • 6.7.4.4. Argentina Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Target Population Analysis
      • 6.8.2.2. Regulatory Landscape
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Target Population Analysis
      • 6.8.3.2. Regulatory Landscape
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Target Population Analysis
      • 6.8.4.2. Regulatory Landscape
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Target Population Analysis
      • 6.8.5.2. Regulatory Landscape
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Neurocognitive Assessment and Rehabilitation Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Company Market Position Analysis
  • 7.3. Strategy Mapping
    • 7.3.1. Expansion
    • 7.3.2. Partnership
    • 7.3.3. Collaborations
    • 7.3.4. Others
  • 7.4. Company Profiles/Listing
    • 7.4.1. Cambridge Cognition Ltd
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Service Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. CogniFit Inc
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Service Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Cogstate Ltd
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Service Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. CNS Vital Signs, LLC
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Service Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Posit Science
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Service Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. HAPPYneuron
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Service Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Constant Therapy Health
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Service Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Neural Assembly Int AB
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Service Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Lumos Labs
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Service Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Cognetivity Neurosciences
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Service Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. SCHUHFRIED GmbH
      • 7.4.11.1. Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Service Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. NeuronUp
      • 7.4.12.1. Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Service Benchmarking
      • 7.4.12.4. Strategic Initiatives
    • 7.4.13. BrainCheck, Inc.
      • 7.4.13.1. Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Service Benchmarking
      • 7.4.13.4. Strategic Initiatives